Rhodes Pharmaceuticals, L.P.

FDA Regulatory Profile

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0794-2021Class IIOxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes PharmacAugust 19, 2021
D-0710-2018Class IIIAptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed April 17, 2018